Topic: CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangioc

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway.

https://www.ncbi.nlm.nih.gov/pubmed/28883618

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.